Molar, Third
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients over 18 years of age; both sexes; without general health impairment according to medical history and physical examination; patients with indication for extraction of bilateral mandibular third molars; impacted; asymptomatic; in class IIB position, according to the Pell & Gregory classification; with similar surgical difficulty
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to any of the components of the medications used; patients who have used anti-inflammatory drugs in the 15 days prior to surgery; patients with tuberculosis, leukocytosis, collagen vascular diseases, multiple sclerosis, HIV infection, and other autoimmune diseases; pregnant and lactating patients; patients with a history of pericoronitis; patients with cognitive disorders that make it impossible to understand and execute commands; patients who withdraw consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of using Tramadol Hydrochloride associated with Nimesulide in controlling pain, edema and trismus after extraction of mandibular third molars. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the clinical efficacy between multimodal therapy using Tramadol Hydrochloride + Nimesulide vs. Dexamethasone in the postoperative control of patients undergoing extraction of mandibular third molars;To assess the anxiety and quality of life of patients undergoing extraction of the lower third molar with each of the medications. | — |
Countries
Brazil
Contacts
Universidade Federal dos Vales do Jequitinhonha e Mucuri - UFVJM